Overview

Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients

Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
0
Participant gender:
All
Summary
This study evaluates the effectivity and safety of MSC implantation on Degenerative Disc Disease Patients by assessing visual analog scale, ROM improvement and MRI examination.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ahmad Jabir Rahyussalim
Criteria
Inclusion Criteria:

1. Patients enrolled in Cipto Mangunkusumo Hospital with degenerative disc disease with
no promising result after conventional treatment.

2. No history of metabolic, autoimun and genetic disease(s).

3. No active infection (HbsAg, HIV, CMV, Rubella).

4. Agree to participate the study by signing informed consent form.

Exclusion Criteria:

1. Patients under 20 years old.

2. Declined to participate in the study.